US 12,453,767 B2
Development of mosaic vaccines against foot and mouth disease virus serotype O
Aida E. Rieder, Westbrook, CT (US); Katherine M. Pflaum, Middletown, CT (US); Fayna C. Diaz San Segundo, Blue Point, NY (US); William M. Fischer, Los Alamos, NM (US); and Tatjana Sitt, Essex, CT (US)
Assigned to The United States of America, as represented by the Secretary of Agriculture, Washington, DC (US); Kansas State University Research Foundation, Manhattan, KS (US); and Triad National Security, LLC, Los Alamos, NM (US)
Filed by The United States of America, as represented by the Secretary of Agriculture, Washington, DC (US); Triad National Security, LLC, Los Alamos, NM (US); and KANSAS STATE UNIVERSITY RESEARCH FOUNDATION, Manhattan, KS (US)
Filed on Aug. 17, 2022, as Appl. No. 17/889,737.
Claims priority of provisional application 63/234,458, filed on Aug. 18, 2021.
Prior Publication US 2023/0149528 A1, May 18, 2023
Int. Cl. A61K 39/135 (2006.01); A61P 31/14 (2006.01); A61K 39/00 (2006.01)
CPC A61K 39/135 (2013.01) [A61P 31/14 (2018.01); A61K 2039/552 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A synthetic polypeptide comprising the amino acid sequence of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, or SEQ ID NO: 10.